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Invited Commentaries
How to optimize the evaluation of carpal tunnel syndrome in patients with polyneuropathy?
Carpal tunnel syndrome (CTS) is the most frequent consequences of the neuropathy and the CTS on nerve peripheral nerve entrapment.
[1] Treatment decision conduction. Development or expertise of new tools is depends on a combination of clinical criteria including always interesting. In this issue, Tokçaer et al propose to tolerance of pain and presence of sensory or motor deficits study the palmar cutaneous nerve, a branch of the median and intensity of electrophysiological abnormalities. nerve which does not pass through the carpal tunnel. Existence of an underlying polyneuropathy in a patient The ratio of conduction velocities of this nerve and the with CTS may complicate the matters since standard first digit median nerve branch appears to be both sensitive electrophysiological explorations are often unable to and specific to detect a CTS in patients with an associated differentiate abnormalities due to the polyneuropathy and polyneuropathy and can thus be used in addition to the entrapment. However, in this situation, conventional methods especially. electrophysiological conclusions are especially important because carpal tunnel syndrome is more frequent in case Jean-Philippe Camdessanche of polyneuropathy, particularly in association with are clearly more sensitive than motor conduction velocities 2. Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients to detect abnormalities.
[3] However, in case of diabetes.
[2]
Thrombolytic treatment in acute cerebral infarction "Hyperacute thrombolysis with IV rtPA of acute ischemic stroke: Efficacy and safety profile of 54 patients at a tertiary referral center in a developing country" in this issue of Neurology India have provided further evidence of the high benefits of timely thrombolytic therapy in acute cerebral infarction.
[2] In the majority of cases, ischemic stroke is caused by an embolus occluding a cerebral artery and early thrombolytic treatment allows re-establishment of bloodflow before a definite and irreversible brain infarction develops. Meta-analysis of studies of thrombolytic therapy confirms that in patients treated within the first 3h after stroke onset, thrombolysis is more effective than placebo in the reduction of mortality rate or functional dependence. The high benefit of thrombolytic therapy with intravenous t-PA is related to the prevention of death or functional dependence in one of each seven patients treated.
[3] Recently, it has been shown that benefits of intravenous t-PA includes not only the use of this agent during the first 3h window after the onset of ischemic stroke, but also up to 4.5h after the onset of symptoms.
[4] In daily practice, however, thrombolysis is used in less than 4% of patients with cerebral infarction mostly due to the fact that patients continue to arrive too late to hospitals, so that the majority 
